Detalhe da pesquisa
1.
Phase 3 randomized trial of mavorixafor, CXCR4 antagonist, in WHIM syndrome.
Blood
; 2024 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643510
2.
Heterozygous variants of CLPB are a cause of severe congenital neutropenia.
Blood
; 139(5): 779-791, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115842
3.
Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients.
J Clin Immunol
; 42(8): 1748-1765, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947323
4.
Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome.
Blood
; 136(26): 2994-3003, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32870250
5.
A prospective study to evaluate febrile neutropenia incidence in patients receiving pegfilgrastim on-body injector vs other choices.
Support Care Cancer
; 30(10): 7913-7922, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35732748
6.
Family studies of warts, hypogammaglobulinemia, immunodeficiency, myelokathexis syndrome.
Curr Opin Hematol
; 27(1): 11-17, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31652152
7.
Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International Registry.
Curr Opin Hematol
; 27(1): 18-26, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31764167
8.
Somatic mutations and clonal hematopoiesis in congenital neutropenia.
Blood
; 131(4): 408-416, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29092827
9.
CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients.
Haematologica
; 105(3): 598-609, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31248972
10.
Neutropenia in Barth syndrome: characteristics, risks, and management.
Curr Opin Hematol
; 26(1): 6-15, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30451719
11.
Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor.
Curr Opin Hematol
; 26(1): 16-21, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30451720
12.
A systematic literature review of the efficacy, effectiveness, and safety of filgrastim.
Support Care Cancer
; 26(1): 7-20, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28939926
13.
An update on the diagnosis and treatment of chronic idiopathic neutropenia.
Curr Opin Hematol
; 24(1): 46-53, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27841775
14.
Association Between Absolute Neutrophil Count and Variation at TCIRG1: The NHLBI Exome Sequencing Project.
Genet Epidemiol
; 40(6): 470-4, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27229898
15.
How I manage children with neutropenia.
Br J Haematol
; 178(3): 351-363, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419427
16.
How I diagnose and treat neutropenia.
Curr Opin Hematol
; 23(1): 1-4, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26554885
17.
Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis.
Blood
; 123(14): 2229-37, 2014 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24523240
18.
CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
; 191(9): 1001-11, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25695403
19.
20.
The diversity of mutations and clinical outcomes for ELANE-associated neutropenia.
Curr Opin Hematol
; 22(1): 3-11, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25427142